AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.
Keep up to date on AgNovos events and related news
AgNovos Healthcare is pleased to announce the publication of a manuscript titled “AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model” in the peer-reviewed journal Bone.
AgNovos Healthcare will participate once again in this year’s German Congress of Orthopedics and Traumatology (DKOU) from October 26-29.
World Osteoporosis Day, marked on October 20th each year, is a day dedicated to raising global awareness of the prevention, diagnosis, and treatment of osteoporosis and related metabolic diseases.
AgNovos Healthcare will participate again in this year’s Bones, Muscles, and Joints conference on October 8th and 9th.
AgNovos Healthcare is pleased to announce an exclusive option agreement with Asahi Kasei Pharma Corporation.
AgNovos Healthcare will participate in this year’s virtual Fragility Fracture Network Congress from September 28-30th.